Thermo Fisher Scientific Acquires Leader in Micro-Volume Spectrophotometers, NanoDrop Technologies
News Oct 10, 2007
The acquisition will strengthen Thermo Fisher's portfolio of UV-Vis spectrophotometry instruments for applications involving small sample volumes. For example, micro-volume samples are used in emerging life sciences research that involves measurement of DNA and proteins. NanoDrop, which is based in Wilmington, Delaware, has annual revenues of approximately $35 million.
"Growing demand from our laboratory customers to accelerate sample preparation time is now compounded by the need to work with smaller sample sizes," said Marijn E. Dekkers, president and chief executive officer of Thermo Fisher Scientific.
"NanoDrop's patented technologies uniquely allow customers to quickly and easily analyze difficult micro-volume samples without the need for dilution. This preserves precious samples to greatly increase laboratory productivity."
NanoDrop currently produces three products - the NanoDrop® ND-1000 and ND-8000 UV-Vis spectrophotometers and the NanoDrop® ND-3300 fluorescence spectrophotometer. These instruments are highly versatile tools that are suitable for a wide variety of laboratories and uses, including life sciences research and industrial applications.
The NanoDrop product line will be integrated into Thermo Fisher's scientific instruments business, part of its Analytical Technologies Segment, and will be marketed under the company's Thermo Scientific technology brand.
Researchers Discover Mutation That Appears to Protect Against Multiple Aspects of Biological AgingNews
The first genetic mutation that appears to protect against multiple aspects of biological aging in humans has been discovered in an extended family of Old Order Amish living in the vicinity of Berne, Indiana, report Northwestern Medicine scientists.READ MORE
Engineering the Gut Microbiome with 'Good' Bacteria May Help Treat Crohn's DiseaseNews
Researchers have singled out a bacterial enzyme behind an imbalance in the gut microbiome linked to Crohn's disease. Replacement of the offending bacteria with "good" bacteria may offer an effective treatment approach.READ MORE
New Player in Alzheimer's Disease Pathogenesis IdentifiedNews
Using proteomics, microscopic analysis, and functional assays, scientists have shown that a protein called membralin is critical for keeping Alzheimer’s disease pathology in check.READ MORE